PTO- 1478 |
Approved for use through 08/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90884810 |
Filing Date: 08/16/2021 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | GLUCOZYME |
*STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | GLUCOZYME |
*MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Unity Research Inc. |
DBA/AKA/TA/FORMERLY | DBA http://mmherbs.com |
INTERNAL ADDRESS | 1019 Hard Rock Road |
*MAILING ADDRESS | 1019 Hard Rock Rd. |
*CITY | Somers |
*STATE (Required for U.S. applicants) |
Montana |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
59932 |
*DOMICILE | XXXX |
PHONE | 406-871-9485 |
*EMAIL ADDRESS | XXXX |
WEBSITE ADDRESS | www.unity-research.com |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Wyoming |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Herbal pills for the treatment of diabetes |
*FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 02/13/2012 |
FIRST USE IN COMMERCE DATE | At least as early as 02/13/2012 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-208123207154-2021081 6133633511854_._Glucozyme _150cc_2021_print3.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\908\848\90884810\xml1\ FTK0003.JPG |
SPECIMEN DESCRIPTION | glucoZyme is specifically designed to aid in the metabolism of all foods, especially all the varieties of carbohydrates, starches, fats, proteins, and fibers. |
WEBPAGE URL | http://www.unity-research.com/en_US/shop/product/glucozyme-14250 |
WEBPAGE DATE OF ACCESS | 08/16/2021 |
ADDITIONAL STATEMENTS INFORMATION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
CORRESPONDENCE INFORMATION | |
NAME | Unity Research Inc. |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | anddrew.escalante@mmherbs.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | andrew.escalante@mmherbs.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 250 |
*TOTAL FEES PAID | 250 |
SIGNATURE INFORMATION | |
* SIGNATURE | /Andrew C. Escalante/ |
* SIGNATORY'S NAME | Andrew C. Escalante |
* SIGNATORY'S POSITION | CEO/CGO |
SIGNATORY'S PHONE NUMBER | 406-871-9485 |
* DATE SIGNED | 08/16/2021 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 08/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90884810 |
Filing Date: 08/16/2021 |
The applicant's current Correspondence Information: |
Unity Research Inc. |
PRIMARY EMAIL FOR CORRESPONDENCE: anddrew.escalante@mmherbs.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): andrew.escalante@mmherbs.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|